Bionano Genomics BNGO
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Bionano Genomics (BNGO) Business Model and Operations Summary
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
Key Insights
Bionano Genomics (BNGO) Core Market Data and Business Metrics
Latest Closing Price
$3.1Market Cap
$8.12 MillionAverage Daily Trade Volume
216,217 SharesPrice-Earnings Ratio
-0.01Total Outstanding Shares
2.73 Million SharesCEO
Dr. Robert Erik Holmlin M.B.A., Ph.D.Total Employees
344Dividend
No dividendIPO Date
August 1, 2018SIC Description
Laboratory Analytical InstrumentsPrimary Exchange
NASDAQHeadquarters
9540 Towne Centre Drive, San Diego, CA, 92121
Historical Stock Splits
If you bought 600 shares of BNGO before August 7, 2023, you'd have 1 share today.
Execution Date | Split Amount |
---|---|
January 27, 2025 | 1-for-60 (Reverse Split) |
August 7, 2023 | 1-for-10 (Reverse Split) |
Cash Flow Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $6.57 Million |
Net Cash Flow From Operating Activities | $-105.18 Million |
Net Cash Flow From Investing Activities, Continuing | $54.27 Million |
Net Cash Flow From Operating Activities, Continuing | $-105.18 Million |
Net Cash Flow From Financing Activities, Continuing | $57.48 Million |
Net Cash Flow | $6.58 Million |
Income Statement
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Net Income/Loss Attributable To Parent | $-204.10 Million |
Other Operating Expenses | $83.13 Million |
Selling, General, and Administrative Expenses | $71.68 Million |
Income Tax Expense/Benefit | $11,000 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Net Income/Loss Available To Common Stockholders, Basic | $-204.10 Million |
Comprehensive Income
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Comprehensive Income/Loss | $-203.80 Million |
Other Comprehensive Income/Loss Attributable To Parent | $307,000 |
Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Comprehensive Income/Loss Attributable To Parent | $-203.80 Million |
Other Comprehensive Income/Loss | $-203.80 Million |
Balance Sheet
July 1, 2023 to June 30, 2024
Metric | Value |
---|---|
Intangible Assets | $30.02 Million |
Equity | $80.34 Million |
Assets | $129.36 Million |
Liabilities And Equity | $129.36 Million |
Liabilities | $49.03 Million |
Equity Attributable To Parent | $80.34 Million |
Historical Dividends
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
No historical dividends |